摘要
从药物临床试验保险的提供和购买情况、政府相关政策法规、监管力度以及受试者和研究者对保险的认识程度,分析我国药物临床试验保险的实施现状及存在的不足,针对我国药物临床试验保险的发展提出相应建议。
From the situation of offer and purchases of clinical trial insurance, the relevant policies and regulations of government, the supervision of regulators, and the awareness degree of researchers and subjects on the insurance, the paper analyzed the implementation status and shortage of drug clinical trial insurance in our country to provide some suggestions for the development of drug clinical trial insurance in China.
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2016年第1期27-31,共5页
Chinese Journal of New Drugs and Clinical Remedies
关键词
临床试验
保险
风险调节
clinical trials
insurance
risk adjustment